Charcoal hemofiltration for hepatic veno-occlusive disease after hematopoietic stem cell transplantation

Bone Marrow Transplantation

Volumn 28, Issue 10, 2001, Pages 997-999

  Tefferi, A ^a   Kumar, S ^a   Wolf, R C ^a   Lacy, M Q ^a   Inwards, D J ^a   Gloor, J M ^a   Albright, R C ^a   Kamath, P S ^a   Litzow, M R ^a  

^a MAYO CLINIC   (United States)

Author keywords

Charcoal hemoperfusion treatment; Transplant related complication

Indexed keywords

ACETYLCYSTEINE; BILIRUBIN; CARMUSTINE; CHARCOAL; CISPLATIN; CORTICOSTEROID DERIVATIVE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; DEFIBROTIDE; DEXAMETHASONE; DOXORUBICIN; MELPHALAN; METHOTREXATE; METHYLPREDNISOLONE; PREDNISONE; PROSTAGLANDIN E1; TOXIN; URSODEOXYCHOLIC ACID; VINCRISTINE;

ADSORPTION; ADULT; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CASE REPORT; DISEASE SEVERITY; DRUG MEGADOSE; ENDOTHELIUM INJURY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOFILTRATION; HEMOSTASIS; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER VENOOCCLUSIVE DISEASE; MALE; MORBIDITY; MORTALITY; PATHOGENESIS; PLASMA CELL LEUKEMIA; PRIORITY JOURNAL; PROTEIN BINDING; T CELL LYMPHOMA; WHOLE BODY RADIATION;

ADULT; BILIRUBIN; CHARCOAL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMOFILTRATION; HEPATIC VENO-OCCLUSIVE DISEASE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 0035202855     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703267     Document Type: Article

References (22)

1. Venocclusive disease of the liver after bone marrow transplantation: Diagnosis, incidence, and predisposing factors
2. Venoocclusive disease of the liver following bone marrow transplantation
3. Hepatic veno-occlusive disease after bone marrow transplant
4. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: A cohort study of 355 patients
5. Treatment of hepatic venocclusive disease with recombinant human tissue plasminogen activator and heparin in 42 marrow transplant patients
6. Treatment of severe veno-occlusive disease with defibrotide: Compassionate use results in response without significant toxicity in a high-risk population
7. Does early treatment with high-dose methylprednisolone alter the course of hepatic regimen-related toxicity?
8. N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation
9. 1 for the prevention of hepatic venocclusive disease after bone marrow transplantation
10. Hepatic veno-occlusive disease after bone marrow transplantation. Immunohistochemical identification of the material within occluded central venules
11. Venocclusive disease of the liver after bone marrow transplantation: The role of hemostasis
12. Early hemostatic alterations following bone marrow transplantation: A prospective study
13. Changes in the natural anticoagulants following bone marrow transplantation
14. Increased plasma level of vascular endothelial glycoprotein thrombomodulin as an early indicator of endothelial damage in bone marrow transplantation
15. Endothelium and bone marrow transplantation
16. Activated charcoal decreases plasma bilirubin levels in the hyperbilirubinemic rat
17. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT)
18. Treatment of severe liver failure with a bioartificial liver
19. Push-pull sorbent-based pheresis for treatment of acute hepatic failure: The Bio-Logic-detoxifier/plasma filter system
20. Activated charcoal as an adjunct to phototherapy for neonatal jaundice
21. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
22. Removal of inhibitors of brain Na+, K+-ATPase by hemoperfusion in fulminant hepatic failure